| Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. | |
| | |
MedLine Citation:
|
PMID: 18849306 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Graves' disease is a common autoimmune disorder in women in fertile ages. The hyperthyroidism is caused by generation of TSH-receptor activating antibodies. In pregnancy both the antibodies and the antithyroid medication given to the mother pass the placenta and affect the foetal thyroid gland. Thyroid function should be controlled not only in the mother with Graves' hyperthyroidism but also in her foetus.The review includes two cases illustrating some of the problems in managing Graves' disease in pregnancy. Major threats to optimal foetal thyroid function are inadequate or over aggressive antithyroid drug therapy of the mother. It should be taken into account that antithyroid drugs tend to block the foetal thyroid function more effectively than the maternal thyroid function, and that levothyroxin (L-T(4)) given to the mother will have only a limited effect in the foetus. Surgical thyroidectomy of patients with Graves' hyperthyroidism does not lead to immediate remission of the autoimmune abnormality, and the combination thyroidectomy+withdrawal of antithyroid medication+L-T(4) replacement of the mother involves a high risk of foetal hyperthyroidism. Conclusion Antithyroid drug therapy of pregnant women with Graves' hyperthyroidism should be balanced to control both maternal and foetal thyroid function. Surgical thyroidectomy of a pregnant woman with active disease may lead to isolated foetal hyperthyroidism. |
| | |
Authors:
|
Peter Laurberg; Claire Bournaud; Jesper Karmisholt; Jacques Orgiazzi |
Related Documents
:
|
1748326 - Second-trimester thyroid function and pregnancy outcome in mothers with hyperthyroidism... 2132426 - Some extrathyroid regulatory mechanisms' aspects in thyroid humoral state at the delivery. 23197546 - Isolated short femur length on second-trimester sonography: a marker for fetal growth r... 14605606 - Consequences of autoimmune thyroiditis before, during and after pregnancy. 14585806 - Effects of immunization against bone morphogenetic protein 15 and growth differentiatio... 2025036 - Iron supplementation, maternal packed cell volume, and fetal growth. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review Date: 2008-10-10 |
Journal Detail:
|
Title: European journal of endocrinology / European Federation of Endocrine Societies Volume: 160 ISSN: 1479-683X ISO Abbreviation: Eur. J. Endocrinol. Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2008-12-17 Completed Date: 2009-01-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9423848 Medline TA: Eur J Endocrinol Country: England |
Other Details:
|
Languages: eng Pagination: 1-8 Citation Subset: IM |
Affiliation:
|
Department of Endocrinology and Medicine, Aalborg Hospital, Aalborg, Denmark. peter.laurberg@rn.dk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antithyroid Agents / therapeutic use* Female Fetus Graves Disease / drug therapy, physiopathology, surgery, therapy* Humans Pregnancy Pregnancy Complications / drug therapy, physiopathology, surgery, therapy* Thyroid Function Tests Thyroidectomy / adverse effects, contraindications |
| Chemical | |
Reg. No./Substance:
|
0/Antithyroid Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus.
Next Document: Relative harm of snus and cigarettes: what do Norwegian adolescents say?